Lian‐Di Kan

429 total citations
18 papers, 332 citations indexed

About

Lian‐Di Kan is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Lian‐Di Kan has authored 18 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Lian‐Di Kan's work include Gastroesophageal reflux and treatments (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Plant-based Medicinal Research (3 papers). Lian‐Di Kan is often cited by papers focused on Gastroesophageal reflux and treatments (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Plant-based Medicinal Research (3 papers). Lian‐Di Kan collaborates with scholars based in China and Czechia. Lian‐Di Kan's co-authors include Liucheng Li, Wencheng Zhou, Hongmei Fang, Zhihui Zhang, Jiao Qu, Liang Xu, Wenhui Cui, Yan Hu, Jie Chen and Qin Chen and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Lian‐Di Kan

17 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lian‐Di Kan China 9 123 105 68 54 42 18 332
Huaqiang Zhai China 10 61 0.5× 140 1.3× 44 0.6× 76 1.4× 37 0.9× 37 363
Kelei Su China 11 63 0.5× 134 1.3× 118 1.7× 79 1.5× 27 0.6× 23 393
Hee-Jae Jung South Korea 12 105 0.9× 116 1.1× 81 1.2× 49 0.9× 35 0.8× 64 405
Yu-Qiong He China 7 97 0.8× 202 1.9× 47 0.7× 55 1.0× 143 3.4× 9 407
Jin F China 12 102 0.8× 134 1.3× 24 0.4× 21 0.4× 48 1.1× 29 410
Jiu-Ling Deng China 7 108 0.9× 225 2.1× 48 0.7× 56 1.0× 166 4.0× 11 453
Daoxin Wang China 9 82 0.7× 136 1.3× 81 1.2× 20 0.4× 115 2.7× 13 386
Ridha Ben Ali Tunisia 10 95 0.8× 73 0.7× 35 0.5× 37 0.7× 11 0.3× 40 336
Natália Alves de Matos Brazil 12 87 0.7× 70 0.7× 22 0.3× 27 0.5× 42 1.0× 29 372
Shivani Jaswal India 8 46 0.4× 89 0.8× 16 0.2× 33 0.6× 43 1.0× 32 361

Countries citing papers authored by Lian‐Di Kan

Since Specialization
Citations

This map shows the geographic impact of Lian‐Di Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian‐Di Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian‐Di Kan more than expected).

Fields of papers citing papers by Lian‐Di Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian‐Di Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian‐Di Kan. The network helps show where Lian‐Di Kan may publish in the future.

Co-authorship network of co-authors of Lian‐Di Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Lian‐Di Kan. A scholar is included among the top collaborators of Lian‐Di Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian‐Di Kan. Lian‐Di Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Qin, Qian, Yuzhen Wang, Lian‐Di Kan, et al.. (2023). Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study. Risk Management and Healthcare Policy. Volume 16. 287–299. 2 indexed citations
3.
Guan, Yan, Liucheng Li, Lian‐Di Kan, & Qiang-min Xie. (2022). Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter‐Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 5044356–5044356. 18 indexed citations
4.
Chen, Jie, et al.. (2022). Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection. Drug Development Research. 84(2). 326–336. 6 indexed citations
5.
Zhu, Xiaobin, Zhihui Zhang, Lihua Sun, et al.. (2021). Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integrative Medicine Research. 10(4). 100778–100778. 8 indexed citations
6.
Jia, Wang, Yan Ren, Lijuan Zhou, et al.. (2021). Glycerol Infusion Versus Mannitol for Cerebral Edema: A Systematic Review and Meta-analysis. Clinical Therapeutics. 43(3). 637–649. 7 indexed citations
7.
Li, Liucheng, Zhihui Zhang, Wencheng Zhou, et al.. (2021). Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management. Drug Design Development and Therapy. Volume 15. 111–124. 13 indexed citations
8.
Li, Liucheng, Xiaobin Zhu, Meng Guo, et al.. (2021). Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019. International Clinical Psychopharmacology. 36(5). 274–278. 7 indexed citations
9.
Jia, Wang, et al.. (2020). Comparative efficacy and safety of glycerol versus mannitol in patients with cerebral oedema and elevated intracranial pressure: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 46(2). 504–514. 3 indexed citations
10.
Li, Liucheng, Zhihui Zhang, Wencheng Zhou, et al.. (2020). Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects. Biomedicine & Pharmacotherapy. 130. 110641–110641. 48 indexed citations
11.
Kan, Lian‐Di, Jie Chen, Yueting Huang, et al.. (2020). Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication. Clinical and Experimental Medicine. 20(4). 609–614. 3 indexed citations
12.
Jie, Ying, et al.. (2019). The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Revista Española de Enfermedades Digestivas. 111(10). 738–743. 20 indexed citations
13.
Li, Liucheng, Liang Xu, Yan Hu, et al.. (2017). Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition. Frontiers in Pharmacology. 8. 513–513. 44 indexed citations
14.
Kan, Lian‐Di, Wei Zhao, Jianwei Xu, et al.. (2017). Peimine inhibits hERG potassium channels through the channel inactivation states. Biomedicine & Pharmacotherapy. 89. 838–844. 6 indexed citations
15.
Li, Liucheng & Lian‐Di Kan. (2016). Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects. Journal of Ethnopharmacology. 198. 45–63. 121 indexed citations
16.
17.
Kan, Lian‐Di, et al.. (2014). A Retrospective Study to Compare the use of Tacrolimus and Cyclosporine in Combination with Adriamycin in Post-Transplant Liver Cancer Patients. Cell Biochemistry and Biophysics. 71(2). 565–570. 3 indexed citations
18.
Kan, Lian‐Di, et al.. (2006). [Chemical constituents of unsaponifiable matter from seed oil of Momordica cochinchinensis].. PubMed. 31(17). 1441–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaqiang Zhai Breakdown of academic impact, for papers by Kelei Su Breakdown of academic impact, for papers by Hee-Jae Jung Breakdown of academic impact, for papers by Yu-Qiong He Breakdown of academic impact, for papers by Jin F Breakdown of academic impact, for papers by Jiu-Ling Deng Breakdown of academic impact, for papers by Daoxin Wang Breakdown of academic impact, for papers by Ridha Ben Ali Breakdown of academic impact, for papers by Natália Alves de Matos Breakdown of academic impact, for papers by Shivani Jaswal
Rankless by CCL
2026